Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Lipton

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge ConferenceRobert E Coleman, Theresa A Guise, Allan Lipton, et al.
Journal of Women'S Health (2002)|October 3, 2023
Beyond October, Beyond Pink: A Year-Round Revelation for Women's Breast HealthRakesh Kumar, Mabel Mardones, Luis Costa, et al.
Cancer|September 10, 2020
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trialPrashanth Moku, Lois Shepherd, Suhail M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Advances in treating metastatic bone cancer: summary statement for the First Cambridge ConferenceAllan Lipton, James R Berenson, Jean-Jacques Body, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Innovations and challenges in renal cancer: consensus statement from the first international conferenceMichael B Atkins, David E Avigan, Ronald M Bukowski, et al.
Breast Cancer Research and Treatment|August 21, 2013
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerAllan Lipton, Laurie Goodman, Kim Leitzel, et al.
Cellular and Molecular Life Sciences : CMLS|March 25, 2022
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor typesNicholas Willumsen, Christina Jensen, George Green, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge ConferenceRobert E Coleman, Theresa A Guise, Allan Lipton, et al.
Journal of Women'S Health (2002)|October 3, 2023
Beyond October, Beyond Pink: A Year-Round Revelation for Women's Breast HealthRakesh Kumar, Mabel Mardones, Luis Costa, et al.
Cancer|September 10, 2020
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trialPrashanth Moku, Lois Shepherd, Suhail M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Advances in treating metastatic bone cancer: summary statement for the First Cambridge ConferenceAllan Lipton, James R Berenson, Jean-Jacques Body, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Innovations and challenges in renal cancer: consensus statement from the first international conferenceMichael B Atkins, David E Avigan, Ronald M Bukowski, et al.
Breast Cancer Research and Treatment|August 21, 2013
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerAllan Lipton, Laurie Goodman, Kim Leitzel, et al.
Cellular and Molecular Life Sciences : CMLS|March 25, 2022
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor typesNicholas Willumsen, Christina Jensen, George Green, et al.
Pageof 15